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Using small-angle X-ray and neutron scattering
(SAXS/SANS), in combination with analytical centri-
fugation and light scattering, we have determined
the solution properties of PFV IN alone and its
synaptic complex with processed U5 viral DNA and
related these properties to models derived from
available crystal structures. PFV IN is a monomer in
solution, and SAXS analysis indicates an ensemble
of conformations that differ from that observed in
the crystallographic DNA-bound state. Scattering
data indicate that the PFV intasome adopts a shape
in solution that is consistent with the tetrameric
assembly inferred from crystallographic symmetry,
and these properties are largely preserved in the
presence of divalent ions and clinical strand transfer
inhibitors. Using contrast variationmethods, we have
reconstructed the solution structure of the PFV inta-
some complex and have located the distal domains
of IN that were unresolved by crystallography. These
results provide important insights into the architec-
ture of the retroviral intasome.
INTRODUCTION
A central event in the retroviral life cycle is the integration of viral
cDNA into the host chromosome (Vogt, 1997; Varmus et al.,
1989). Retroviral integrases (IN) mediate this event by recog-
nizing specific attachment sites at the end of long terminal
repeat (LTR) regions of the viral genome (U5 and U3) to catalyze
two distinct chemical reactions: a 30 cleavage reaction that
exposes the 30-OH groups of the conserved CA dinucleotide
and a strand transfer step that inserts these 30 termini of the
viral cDNA into the host chromosome via a transesterifcation
reaction. These reactions are catalyzed by oligomers of inte-
grase that exist as parts of distinct nucleoprotein intermediates:
a stable synaptic complex (SSC), in which two viral DNA ends1918 Structure 20, 1918–1928, November 7, 2012 ª2012 Elsevier Ltdare associated with a tetramer of IN, a target capture complex
(TCC), in which the SSC binds to target DNA, and the strand
transfer complex (STC), where the viral DNA ends are subse-
quently integrated into the target DNA (Li et al., 2006). Inhibitors
that target these nucleoprotein complexes in HIV, such as Ralte-
gravir and Eltegravir, are effective in the clinical setting (Arts and
Hazuda, 2012).
All retroviral INs share three domains: an N-terminal domain
(NTD), a catalytic core domain (CCD), and a C-terminal domain
(CTD) (Figure 1A). The NTD contains conserved histidine and
cysteine residues that bind Zn2+, and the domain plays a role
in oligomerization and the enzyme’s catalytic function. The
CCD contains an RNase H-like fold, well-conserved among the
retroviral integrases, with conserved D-D-E active-site residues
common to polynucleotidyl transferases. In contrast, the CTD
is poorly conserved among the retroviral integrases, featuring
an SH3-like fold that has been implicated in DNA binding and
tetramerization (Jenkins et al., 1996). INs from Spumavirus and
Gammaretrovirus are further distinguished by the presence of
N-terminal extension domains (NEDs) that precede the con-
served NTDs (Hare et al., 2010). Many one- and two-domain
high-resolution structures of HIV IN and other related retrovi-
ruses, both alone and in complex with the integrase binding
domain (IBD) of the host factor LEDGF are now available (for
a recent review, see Jaskolski et al., 2009).
Our understanding of the mechanism of retroviral integration
advanced with the determination of the crystal structures of
prototype foamy virus (PFV) IN in complex with minimal pro-
cessed viral U5 DNA (Figures 1B and 1C; Figure S1 available
online) (Hare et al., 2010; Maertens et al., 2010). These inta-
some structures provide molecular insights into the sequential
steps of retroviral integration and its inhibition, including views
of the SSC, TCC, and STC intermediate states, all in the pres-
ence and absence of divalent ions and clinical inhibitors.
However, little is known about the properties of these nucleo-
protein assemblies as they exist in solution. In all of the avail-
able PFV intasome crystal structures, the same quaternary
arrangement is observed via crystallographic symmetry: two
integrase subunits comprise the core of the complex, providing
all of the protein-protein interactions, which hold the tetrameric
assembly together, the interactions with viral DNA, and theAll rights reserved
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Figure 1. Construct of PFV IN Used in This Study
(A) Comparison of the HIV and PFV IN domain structures.
(B) PFV IN active monomer structure.
(C) Intasome structure (Protein Data Bank [PDB] ID code 3L2Q), as inferred from crystallographic symmetry. The active DNA-bound monomers are shown in red
and blue, respectively. Inactive monomers are colored in yellow and cyan. Cartoons depict the missing NED/NTD and CTD domains not resolved in the electron
density.
See also Figure S1.
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PFV IN-DNA Complexes in Solutionactive sites that mediate integration. The two remaining sub-
units, in contrast, are not fully resolved, as only the CCD
domains are observed at the distal ends of the complex, with
the NTD and CTD unobserved in the electron density (Fig-
ure 1C). The roles of these inactive subunits in complex forma-
tion and retroviral integration are unknown. Furthermore, it is not
known if drug-bound nucleoprotein complexes have quaternary
properties that are distinct from their native form; in available
PFV structures with inhibitors bound, no large conformational
differences have been observed within the crystal lattice. The
PFV integrase model system provides an ideal opportunity to
directly relate the solution properties of these nucleoprotein
assemblies with and without bound inhibitors to the known
atomic resolution models of the intermediates involved in retro-
viral integration.
In this study, we report the solution properties of PFV IN and
its complex with processed U5 viral DNA. Using size-exclusion
chromatography in-line with multiangle light scattering (SEC-
MALS) and analytical ultracentrifugation, we have established
the mass, stochiometry, and hydrodynamic properties of PFV
IN and its complex with processed U5 DNA. We have used
small-angle X-ray and neutron scattering (SAXS/SANS) analyses
of these preparations to investigate the effects of divalent ions
and strand transfer inhibitors on overall shape. Contrast variation
analysis using SAXS and SANS data together has allowed us
to locate previously unobserved domains in the PFV intasome
and to directly reconcile the solution conformations of these
macromolecules with available crystallographic models. Our
studies reveal properties not apparent from available structures
that can be directly related to other retroviral integrases, in-
cluding HIV.Structure 20, 1918–19RESULTS
PFV IN Is Monomeric Prior to Binding DNA
The first studies on the solution behavior of PFV IN alone
reported a monomer-dimer equilibrium in solution, with a
20–30 mM Kd by fluorescence methods (Delelis et al., 2008).
We examined a range of concentrations of PFV IN using comple-
mentary approaches. By size-exclusion chromatography in-line
with multiangle light scattering (SEC-MALS), only monomers
are observed at concentrations up to 10 mg/ml (225 mM) (Fig-
ure 2A), affirming the suitability of these preparations for small-
angle scattering analysis (Rambo and Tainer, 2010a). Modeling
the Lamm equation to the sedimentation velocity data mirrors
these observations, with only a single species observed at 2.9
S20,w and a frictional ratio (f/fo) of 1.4 (Figure 2B). Combining
these sedimentation velocity results with parameters derived
from in-line quasielastic light scattering allows for a determined
mass of 45 kD (Siegel and Monty, 1966), consistent with the
monomeric size determined from multiangle light scattering.
Using sedimentation equilibrium analysis, the best global fit
over a range of concentrations and speeds at 25C is also for
a single-species monomer (Figure 2C; Table S1).
SAXS Analysis of PFV IN
The solution properties of PFV IN were further investigated using
small-angle X-ray scattering (SAXS). Representative scattering
data are shown in Figure 3A. Guinier plots are linear for each of
the concentrations analyzed, and the parameters derived are
consistent with those from GNOM analysis, indicating monodis-
persity (Tables 1 and S2). Mass determination by comparing the
intensity of scattering extrapolated to zero angle (I(0)) with28, November 7, 2012 ª2012 Elsevier Ltd All rights reserved 1919
Figure 2. Hydrodynamic Properties of PFV IN and PFV Intasome
(A) SEC-MALS analysis of PFV IN (blue) and PFV intasome (red). The ABS280 elution profile from a Superdex 200 analytical column at 25
C is shown as solid lines.
Representative mass profiles determined by light scattering are shown as red (PFV intasome,Mw = 178,800 ± 7,500, n = 3) or blue squares (PFV IN, Mw = 43,800 ±
3,200, n = 10).
(B) Sedimentation velocity analysis. Shown in upper two panels are the experimental data collected for PFV IN alone (upper left) and PFV intasome (upper right),
rendered as black points on solid black lines that are the fits to the Lamm equation (root-mean-square deviations [rmsds] of 0.007 and 0.008, respectively). Each
boundary shown corresponds to a 30 s time interval; data are shown only for the initial boundaries. Residuals, showing the agreement between the absorbance
data collected and the theoretical fit, are shown below each panel as a function of the radius of the experimental cell. Shown in the lowest subpanel are the derived
c(S) distributions for PFV IN (blue line, S20w = 2.9) and PFV intasome (red line, S20w = 8.5).
(C) Sedimentation equilibrium analysis of PFV IN. Global fits were performed at three concentrations at three rotor speeds and are best fit to a single-species
monomer model; rotor speeds are denoted in the figure legend. Top panels show radial absorbance data (symbols) and single-species model fits (lines); lower
panels show residuals from the model fit.
A summary of the biophysical parameters derived from these analyses is shown in Table S1.
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PFV IN-DNA Complexes in Solutiona protein standard of known concentration and mass also
indicated monomers (Table S2). Three different preparations of
recombinant PFV were analyzed at four different experimental
sources, including both X-ray and neutron scattering (Tables 1,
2, S2 and, S3). The radius of gyration (Rg) for the monomer
is constant over the range of concentrations tested (Fig-
ure 3B; Table S2), and Kratky plot analyses indicate a folded
macromolecule.
The hydrodynamic parameters of a PFV monomer calculated
from PFV intasome crystal structure coordinates largely agree
with the sedimentation coefficient (S20,w) and frictional coeffi-
cient (f/fo) determined by sedimentation velocity (Table 3).
However, the calculated Stokes radius (Rs) is larger than that
observed by gel filtration. SAXS data support a similar conclu-
sion: data extrapolated to infinite dilution indicate that both the
Rg and maximum dimension (Dmax) of the IN monomer differ1920 Structure 20, 1918–1928, November 7, 2012 ª2012 Elsevier Ltdfrom that predicted from the available crystallographic structure
of intact IN (Figure 3C). These comparisons indicate a difference
in monomeric structure in solution between the DNA-bound and
unbound forms.
Shape reconstruction algorithms using scattering data allow
for direct reconciliation of available atomic structures with
their solution properties. However, low-resolution models of
PFV IN reconstructed from SAXS data failed to produce a
consensus solution, as indicated by large normalized spatial
discrepancy (NSD) figures and visual disparity between indi-
vidual reconstructions (Figure S2). These results indicated that
an alternative approach was necessary to reconcile atomic
structure with solution properties. To accomplish this, we imple-
mented an atomistic modeling approach (Curtis et al., 2012),
which involved sampling many conformations by molecular
Monte Carlo and energy minimization and comparing theAll rights reserved
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Figure 3. SAXS of PFV IN
(A) Representative SAXS data from PFV IN, shown as the recorded intensity as a function of q (A1), where q = 4psinq/l and 2q is the scattering angle. Error bars
represent plus and minus the combined standard uncertainty of the data collection.
(B) In the inset, radius of gyration (Rg) plotted as a function of protein concentration. Experimental sources, where data were recorded, are noted in the figure
legend.
(C) P(r) analysis of SAXS data recorded for PFV IN at 5 mg/ml (blue line). Shown in red is P(r) function calculated for the active monomer of PFV IN observed within
the crystal lattice of the PDB ID code 3L2Q.
See Figure S2 for SAXS reconstructions based on this data.
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PFV IN-DNA Complexes in Solutioncorresponding theoretical SAXS profiles to the experimental
data. To generate a conformational ensemble, the backbone
dihedral angles of the linkers connecting NTD and CTD to the
CCD and terminal regions were allowed to vary in a manner
consistent with their lack of secondary structure, predicted
mobility, and disorder predicted by bioinformatics.
From a pool of over 50,000 theoretical structures that ranged
in Rg from 34 to 65 A˚ (Figure 4A), the best-fit structure (c
2 =
2.7, Figure 4C) shows an extended conformation distinct from
the starting model. However, solution scattering in this case
more likely represents the average of many different conforma-
tions (Bernado´ and Svergun, 2012). An analysis of the range of
structures that correspond to the ensemble of best-fit structures
(where c2 < 10) is shown as isodensity plots shown in Figure 4D.
Because the physical dimensions of the ensemble covered
a much larger region of configurational space than that found
for the best-fit structures (Figure S2), our analysis indicates
that PFV IN adopts a compact subset of configurations relative
to those considered by allowing flexible interdomain linkers.
We next applied the minimal ensemble search (MES) method
to the pool of structures created, which identifies a minimal
ensemble of structures required to best describe the experi-
mental data using a genetic algorithm (Pelikan et al., 2009). Using
this approach, a minimal ensemble of four selected conformers
greatly improved the concordance with the experimental data
(x2 = 1.4) and suggests that PFV IN exists as a relatively compact
ensemble where the CTD and NTD are flexibly linked to the CCD
(Figure 4). The calculated solution properties of these models,
both individually and as an ensemble, are consistent with the
solution properties of PFV IN determined by analytical centrifu-
gation, light scattering, and SAXS (Table 3). Combined, these
results indicate that IN undergoes a significant conformational
change upon binding to DNA, oligomerization, and assembly of
the intasome.
Solution Structures of the PFV Intasome
We next employed complementary approaches to confirm the
stochiometry of the intasome. Using the Siegel and Monty rela-Structure 20, 1918–19tionship with centrifugation and quasielastic light scattering
data, we estimated a molecular weight of 195 kD for the com-
plex, in good agreement with the 4:2 IN:DNA stochiometry in-
ferred from crystallography and indicated by biochemical data
from different species of IN (Table S1) (Bao et al., 2003; Faure
et al., 2005; Li et al., 2006). Further corroborating these results
are SEC-MALS analyses using a mass-averaged dn/dc based
on this stochiometry, which provides a calculated Mw of 185
kD at peak value (Figure 2A). The PFV intasome is discrete and
monodisperse in solution, with no evidence of higher order
species or partially assembled intermediates (Figure 2B).
To investigate the molecular shape of this complex in solution,
X-ray scattering experiments were carried out on intasome prep-
arations across a range of concentrations (1–10 mg/ml) at two
different synchrotron sources (Figure 5A; Tables 1 and S2). Scat-
tering data were measured for complexes in the presence and
absence of Mg2+ and the clinical inhibitors Raltegravir (Havlir,
2008) and L-731,988 (Espeseth et al., 2000). Because the prop-
erties of the PFV intasomewere nearly identical in these different
solution conditions as evidenced by P(r) analysis of SAXS data
(Figure 5B), we limited our subsequent scattering analyses to
the apo form of the intasome.
For our analysis, we constructed a model of the PFV intasome
that includes the missing NTDs and CTDs (Figure 5C). These
domains were generated by applying the local 2-fold symmetry
operation that relates the active and inactive CCD subunits.
Hence, the initial modeled NTD and CTD positions are related
by 2-fold symmetry to the corresponding domains in the intact
subunits (Figure S3). In this extended configuration, the com-
plete intasome model has a maximum dimension of 250 A˚ and
a calculated Rg of 58 A˚. In contrast, X-ray scattering data indi-
cates that the intasome has an Rg of 50 A˚ and maximum
dimension of 180 A˚, parameters that are both significantly
smaller than that predicted for the extended configuration shown
in Figure 5C. This analysis indicates that the components of the
complex are, on average, positioned closer to the center of mass
of the particle than is suggested by the extended arrangement.
To examine the possibility that the inactive subunit NTD and28, November 7, 2012 ª2012 Elsevier Ltd All rights reserved 1921
Table 1. Parameters Derived from SAXS for PFV IN and PFV Intasome
Sample Source Concentrationa Rg
b Dmax
b
PFV IN ALS SIBYLS (SAXS) 5 37.4 ± 0.1 135
4 38.5 ± 0.1 140
3 36.8 ± 0.1 135
2 35.9 ± 0.2 140
inf. 34.9 ± 0.2 140
NIST NG-3 (SANS) 6.2 37.4 ± 2.5 140
PFV-U5 Cornell G1 (SAXS) 10 50.0 ± 0.1 180
5 49.8 ± 0.2 180
ALS SIBYLS (SAXS) 3 48.0 ± 0.1 165
1.5 46.2 ± 0.2 165
+10 mM MgCl2 3 50.4 ± 0.2 165
1.5 46.2 ± 0.2 165
+10 mM MgCl2 and 5 mM L-791-833 3 49.6 ± 0.1 165
2 50.7 ± 0.2 175
1 50.2 ± 0.4 175
+10 mM MgCl2 and 5 mM Raltegravir 3 48.6 ± 0.3 170
2 49.7 ± 0.2 175
U5 Alone 2 19.8 ± 0.1 70
1 19.9 ± 0.1 65
aAs determined by I(0) analysis using a known protein standard (protein alone), Bradford assay (protein-DNA complex), or by theoretical extinction
coefficient (DNA alone). Values shown are in units of mg/ml.
bAs determined using GNOM (Semenyuk and Svergun, 1991). Values shown are in units of angstroms (A˚). An extended table for parameters derived
from SAXS is provided in Table S2.
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PFV IN-DNA Complexes in SolutionCTD domains are disordered, we generated 50,000 models,
which differ in the position of the distal NTD and CTD domains
via their flexible NTD-CCD and CCD-CTD linkers and compared
their theoretical scattering profiles to the experimental data (Fig-
ure 5D). Unlike the results derived for IN alone by this type of
analysis, none of these modeled intasome configurations, either
individually or as an ensemble, could capture the spatial proper-
ties indicated by scattering. This modeling suggests that an
ordered, compact, and discrete configuration can account for
the observed solution properties.
To better ascertain the disposition of the protein and DNA
components of this complex, we combined SAXS with small-
angle neutron scattering (SANS), which allows for the discrimina-
tion of the parts of a composite particle when the H2O:D2O ratios
in the solvent are varied (the contrast variation approach) (Stuhr-
mann, 1974). Neutron scattering data were recorded at five
different contrast points, including the 65% D2O match point
predicted to coincide with the experimental match point for
protein only (Figure 6A; Table 2). The dependence of Rg on the
contrast of the individual components and their relative positions
in the composite particle was determined using the Stuhrmann
equation (Stuhrmann, 1974). A plot of this relationship using
the five SANS contrast points and SAXS data reveals a linear
trend with essentially no slope (within the error of the determina-
tion, Figure 6B); similar results are obtained both with and
without the X-ray data point. The slope and linearity of this trend
do not support a placement of the DNA component at the
periphery of this assembly, which would manifest itself with a
hyperbolic or positively sloped linear line in a plot of between
Dr versus Rg
2, as was observed for the nucleosome (Hjelm1922 Structure 20, 1918–1928, November 7, 2012 ª2012 Elsevier Ltdet al., 1977). Instead, these results are most consistent with
a DNA position near the center of mass, consistent with what
is seen with the PFV intasome crystal structures. The protein
component underlies the maximum interatomic distances ob-
served in this complex, consistent with the protein arrangement
inferred from available crystal structures. Consistent with this,
the Rg values obtained for the 90% H2O and 80% D2O mix-
tures by neutron scattering, where the protein scattering con-
tribution is the strongest, are the largest of those obtained
from the contrast variation series. By both Stuhrmann plot anal-
ysis and the parallel axis theorem (Figure 6B; Table 2), protein-
only Rgs of 53.7 and 56.6 A˚, respectively, were obtained, which
also support a placement of the protein component on the
periphery of the complex. Further supporting data are presented
in Figure S4.
Shape Reconstruction of PFV IN by Simultaneous Fitting
of SANS and SAXS Data
To establish the relative positions of the protein and DNA
components of the intasome independently, shape restoration
was performed using a multiphase bead approach (Svergun,
1999) that simultaneously fit five SANS profiles and one SAXS
profile. Based on the established 4:2 protein:DNA stochiometry
and the domain organization in available crystal structures, we
employed 2-fold symmetry constraints in the calculations. The
results are shown in Figure 7A, with galleries of reconstructions
and representative data fits to experimental data shown in Fig-
ure S5. Both SANS data alone and SANS in combination with
SAXS data yielded similar shapes with similar positions of the
protein and DNA components (data not shown). The results ofAll rights reserved
Table 2. Parameters Derived from SANS for the PFV Intasome
Source H2O:D2O Concentration
a Rg
b Dmax
b
NIST NG-3
(SANS)
0% D2O 6.7 51.6 ± 0.3 155
0% D2O 3.9 49.1 ± 1.6 155
20% D2O 7.3 53.7 ± 2.5 175
65% D2O 8.3 52.9 ± 0.6 160
80% D2O 7.7 53.0 ± 0.3 165
90% D2O 7.8 51.3 ± 0.3 160
90% D2O 3.9 49.1 ± 0.6 160
Stuhrmann relationshipc SE
Rc (A˚) 50.8 ±0.9
Protein Rg (A˚) 53.7 ±1.5
a 1.2 ±158.4
b 473.8 ±323.0
Parallel axis theoremc
Protein Rg (A˚) 56.6 ±3.4
aDetermined by Bradford protein assay. Values shown are in units
of mg/ml.
bDetermined by GNOM analysis (Semenyuk and Svergun, 1991). Values
shown are in units of angstroms (A˚). An extended table for parameters
derived from SAXS is provided in Table S3.
cDetermined by MuLCH analysis (Whitten et al., 2008).
Table 3. Comparison of Calculated Properties of Structural
Models with Their Experimental Values
PFV IN alone Rg
a Dmax
a Rs
a S f/fo
Model properties
Crystallographic active subunit 35.8 122 40.7 2.5 1.2
Best single-state solution 38.6 144 42.7 2.4 1.4
MES solutions
Model 1 38.8 140 43.9 2.3 1.3
Model 2 37.7 126 42.4 2.4 1.2
Model 3 63.3 205 50.9 2.0 1.5
Model 4 34.4 126 37.3 2.7 1.2
Inactive subunit in
SAXS/SANS-derived intasome
31.3 107 39.3 2.6 1.3
Experimental 34.9 140 28.7 2.9 1.4
PFV intasome
Model properties
Starting extended model 62.2 267 71.4 6.8 1.4
SAXS/SANS-derived model 57.2 215 65.8 7.4 1.2
Experimental 50.0 180 51.6 8.5 1.6
MONSA bead model 46.4 192 52.3 9.2 1.4
aValues shown are in units of angstroms (A˚).
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PFV IN-DNA Complexes in Solutionten independent calculations yielded similar results, with c2
values ranging from 0.82 to 3.7 for each of the six scattering
profiles used (Figure S5); these ten calculations were combined
to yield the final averaged and filtered reconstruction. The result-
ing bead model is a prolate ellipsoid with dimensions of 180 3
75 3 53 A˚, with calculated S and Rs values in good agreement
with those determined experimentally (Table 3). The PFV inta-
some crystal structure was readily docked into this envelope
(Figure 7B), confirming the inferred quaternary arrangement
from crystallographic symmetry: the protein component forms
a continuous assembly that surrounds the smaller DNA compo-
nent located at the center of the complex.
The most obvious discrepancy is the presence of additional
protein components, present as lobes on the distal ends of the
elongated envelope (arrows in Figure 7B). When our starting
model of the intact PFV intasome was placed into the envelope,
the NTD and CTD domains missing from the crystal structure
model were found to protrude outside of the protein component
of the reconstruction, indicating that they adopt conformations
that are distinct from those found in the active IN subunit (Fig-
ure 7C). Because the NTD-CCD and CCD-CTD linkers in PFV
IN allow for considerable flexibility, the rigid body motions
necessary to model these domains into the vacant distal lobes
were readily performed (Figure 7D). The final model captures
the gross features of the SAXS data and molecular envelope
(Figure S4C, c2 = 2.8) and maintains good stereochemistry,
with greater than 97% of the residues in allowable regions of
the Ramachandran plot.
As anticipated, the configuration of the inactive subunits in the
PFV intasome is distinct from that observed with the active
subunits, differing in the positioning of NTD and CTDs relative
to the CCD (Figure 7E). It is immediately apparent why these
domains were not observed in the crystallographic structures:Structure 20, 1918–19crystal lattice contacts in the crystal form used to determine
the PFV-DNA complex structures would interfere with these
configurations because of severe steric clashes (Figure S1).
Presumably, the crystal packing interactions are favored ener-
getically over the inactive subunit NTD and CTD interactions,
resulting in their displacement and disorder in the crystal.
The most significant difference remaining between the PFV
intasome model and the shape reconstruction involves the
trajectory of the viral DNA ends (denoted with cyan arrows in
Figure 7D). In PFV IN-U5 crystal structures, the viral DNA
arms contribute significantly to crystal lattice formation. The
ends of the DNA to be processed are lodged in the active
sites of the active subunits, whereas the opposite ends of the
DNA dock into the active sites of inactive subunits from a neigh-
boring asymmetric unit (Figure S1). Although scattering data
clearly support the central location of the DNA component
within the composite particle, the reconstruction suggests a
slightly different orientation of the DNA compared to that ob-
served in the crystal structure. The solution results suggest
that the two viral DNA arms exit the protein core at a more
shallow angle with respect to the long axis of the particle ellip-
soid (i.e., the DNA is more parallel to the overall intasome
particle) and are nested deeper within the protein component.
This observation is reminiscent of atomic force microscopy
measurements made on HIV SSC complexes, where a more
parallel distribution of DNA arm alignments was also observed
(Kotova et al., 2010). We chose not to model this aspect of
the intasome, because doing so would require a relatively large
number of adjustable parameters to accommodate significant
changes in protein conformations. Further indication of the
modest differences between our final intasome model shown
in Figure 7D and its expected behavior in solution are reflected
in the calculated versus experimental hydrodynamic parameters
shown in Table 3.28, November 7, 2012 ª2012 Elsevier Ltd All rights reserved 1923
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Figure 4. Atomistic Modeling of PFV IN
(A) Plot of the Rg values for all 50,000 models obtained by conformational sampling versus their correlation with the experimental SAXS data (as measured by c
2).
The values for the best single solution (cyan circles) and the conformational ensemble with the four select conformers (orange circles) are indicated.
(B) The ensemble fit to the experimental data (black) is shown as a red line on a plot of intensity versus q. The theoretical scattering from the crystallographic
conformation of PFV IN is shown as a green line.
(C) Comparison of the crystallographic configuration of PFV IN (magenta) with its best single state solution (cyan), as derived from conformational analysis.
(D) Structure density plot. Isodensity surface plot showing the conformation space occupied by the best fit structures of the ensemble with c2 < 10.0 (blue mesh).
Further indicated as solid densities is the allowed variability in subregions of the structure: residues 1–10 (red), 47–51 (orange), 102–125 (yellow), 270–287 (green),
302–321 (blue), 326–346 (cyan), and 375–395 (purple).
(E) The ensemble solution, shown at orthogonal angles and aligned relative to the CCD. The calculated contributions of the ensemble to its scattering areModel 1
(red), Rg of 38.8 A˚ (c
2 = 2.72, 27.0% of the contributing scatter); Model 2 (orange), Rg of 37.7 A˚ (c
2 = 3.31, 41.0%); Model 3 (yellow), Rg of 63.3 A˚ (c
2 = 11.9, 8.0%);
and Model 4 (green), Rg of 34.4 A˚ (c
2 = 6.03, 22.0%).
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PFV IN-DNA Complexes in SolutionDISCUSSION
The primary goal of this study has been to determine the solution
properties of PFV IN and its minimal complex with processed
viral U5 DNA in order to identify aspects of the complex that
are not available or that differ from the crystallographic models,
including the location of distal domains not resolved in the crystal
structure and the solution properties of drug-bound complexes.
Although small-angle scattering techniques lack the resolution to
visualize structures at high resolution, these approaches can
provide rigorous tests for models of quaternary structure and
can reconcile structural models of large macromolecular assem-
blies with their solution properties (Putnam et al., 2007; Rambo
and Tainer, 2010b). The use of SANS has the added value of
contrast, providing the ability to isolate the protein and DNA
components of the composite particle.
A common feature of most retroviral integrases characterized
to date is the formation of dimers and tetramers; in different
systems, these preassembled oligomers have been directly
linked to the native assembly of nucleoprotein intermediates1924 Structure 20, 1918–1928, November 7, 2012 ª2012 Elsevier Ltdand to catalysis (Bao et al., 2003; Deprez et al., 2000, 2001; Li
et al., 2006). In the case of the lentiviruses, the binding of the
cellular cofactor LEDGF modulates IN oligomerization (Gupta
et al., 2010; Hayouka et al., 2007). In contrast, we show that
PFV IN is exclusively monomeric prior to binding processed viral
U5 DNA, underscoring another important difference among
retroviral integrases. It is currently unknownwhich, if any, cellular
host factors might modulate this process for PFV IN or if PFV IN
plays a role in other aspects of its retroviral life cycle, as seen in
HIV IN with uncoating (Briones et al., 2010), assembly (Zhang
et al., 2011), and reverse transcription (Nishitsuji et al., 2009;
Warren et al., 2009). The assembly of PFV IN monomers to
form synaptic complexes may also be important to under-
standing the steps of intasome assembly in HIV IN, because
recent fluorescent and biochemical measurements indicate
that HIV IN monomers and dimers play a prominent role in the
assembly of the intasome and in concerted strand transfer
(Bera et al., 2009; Deprez et al., 2001; Pandey et al., 2011).
Our measurements confirm that the stochiometry and qua-
ternary arrangement of the IN tetramer derived for the PFVAll rights reserved
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Figure 5. SAXS of PFV Intasome
(A) Representative SAXS data from the PFV
intasome, shown as recorded intensity as a
function of q. Error bars represent plus and minus
the combined standard uncertainty of the data
collection.
(B) P(r) analyses of PFV intasome in different
solution conditions, including divalent ion and
strand transfer inhibitors.
(C) Initial extended model of the PFV intasome,
representing the complete inventory of the 4:2
protein-DNA assembly. Shaded in boxes are
the NTD and CTD domains from the inactive
subunits missing from available crystallographic
structures that were varied in conformational
sampling.
(D) Plot of Rg values for 50,000 conformations
created by introducing torsional degrees of
freedom in the linkers connecting NTD and CTD to
the CCD in the inactive subunits. A horizontal
black line corresponds to the Rg derived from
SAXS for the PFV intasome.
See also Figure S3.
Structure
PFV IN-DNA Complexes in Solutionintasome from its crystal lattice configuration reflects its gross
properties in solution and that these properties are largely
preserved in the presence of divalent ions and clinical inhibitors.
It is clear from our analysis that two distinct species of IN
subunits reside within the intasome: an active pair of subunits
mediating tetramerization, DNA binding, and catalysis and an
inactive pair of subunits in a distinct configuration that is not
competent for DNA binding. The discrete positions identified
here for the NTD andCTDof the inactive subunits raise questions
about the possible functional role for this inactive configuration
and the apparent redundancy in composition of the intasome.
One possibility is that these distal domains ensure the fidelity
of synapsis and strand transfer by precluding unwanted DNA
interactions that would otherwise disfavor concerted strand
transfer.
Another possibility is that the inactive NTDs and CTDs provide
stabilizing interactions with the viral DNA or with other proteins
within the preintegration complex, interactions that cannot be
addressed with the minimal substrates utilized in this study or
in the crystallographic models. Indeed, assembly of HIV-1 inta-
somes requires several hundred base pairs of DNA, in addition
to the terminal viral DNA sequences (Li et al., 2012). The distal
domains might also stabilize the intasome during target capture
by interacting with chromatin and/or target DNA. Based on the
PFV intasome model described in this study, it seems unlikely
that these interactions would be possible without significant
conformational changes on the part of the inactive subunits
because the positions of the distal domains are remote from
the target DNA binding site indicated by available PFV STC
structures (Maertens et al., 2010).
Lastly, these outer domains may function outside of the scope
of catalysis to recruit host factors to the preintegration complex
(PIC) and ultimately the site of integration. For example, the
cellular double-strand break repair proteins Rad51 (CosnefroyStructure 20, 1918–19et al., 2012; Desfarges et al., 2006), Ku (Zheng et al., 2011),
and Rad18 (Mulder et al., 2002) have all been reported to interact
with IN and may play a role in repairing the gaps in retroviral DNA
integration intermediates to complete the creation of provirus
(Yoder and Bushman, 2000).
Because of the homology of PFV IN to HIV IN and the
conserved biochemical aspects of concerted integration among
all of the retroviral integrases, it is expected that the PFV
intasome should largely mirror the assembly made by HIV IN
with viral DNA. Indeed, an HIV intasome homology model based
on the PFV intasome structures has recently been reported
(Krishnan et al., 2010). In a similar fashion, an HIV intasome
model using the SAXS/SANS-derived PFV intasome presented
here as the template can be rendered (Figure S5). This model
recapitulates the overall features of that described by Krishnan
et al. (2010) and builds upon their findings by providing insight
into the possible nature of the distal domains of the inactive
monomers in this integration assembly. In contrast, cryo-EM
reconstructions of LEDGF-bound IN tetramers with and without
DNA (Michel et al., 2009) suggest a quaternary arrangement that
is largely different in the configuration of the inactive monomers.
Comparative structural and biophysical studies of HIV IN nucle-
oprotein complexes may yield further insights into these issues.EXPERIMENTAL PROCEDURES
Expression and Purification of PFV IN and Preparation of Intasomes
The purification of full-length PFV IN (IN 1-392) was carried out as previously
described (Valkov et al., 2009). The purified protein was concentrated to
5–12 mg/ml in 50 mM Tris–HCl (pH 7.4), 320 mM NaCl, 10 mM DTT, and
20% (v/v) glycerol before flash-freezing in liquid N2 and storage at 80C.
Protein concentration was determined by Bradford assay (Bio-Rad Laborato-
ries, Hercules, CA, USA).
Preprocessed U5 LTR Oligonucleotides previously described (Hare et al.,
2010) were synthesized on a Mermade 4 (Bioautomation, Plano, TX, USA)28, November 7, 2012 ª2012 Elsevier Ltd All rights reserved 1925
Figure 6. SANS Analysis of the PFV Intasome
(A) Small-angle neutron scattering data for the PFV intasome, shown as
intensity as a function of q for five different H2O:D2O ratios (0%, 20%, 65%,
80%, and 90% D2O). Error bars represent plus and minus the combined
standard uncertainty of the data collection.
(B) The corresponding Stuhrmann Plot analysis is shown in the inset. Error bars
represent the statistical uncertainty of the fitting parameters and are smaller
than the data points. The Rg values for the complex are related to contrast by
this relationship Rg
2 = Rc
2 + a/r  b/r2, where Dr is the mean contrast for the
complex, Rc is the Rg of the complex at infinite contrast, and a and b are
scattering density-related coefficients. The term a describes the distribution of
scattering densities relative to the center of mass, and the term b relates to the
separation of the mass centers of the two components. Experimental data
points recorded in this study are shown as open circles; theoretical points for
the model shown in Figure 5C are shown as dark squares, and theoretical
points for the crystallographic structure of the intasome (with inactive mono-
mer NTD and CTD domains excluded) are shown as dark triangles.
See also Figure S4.
Structure
PFV IN-DNA Complexes in Solutionoligonucleotide synthesizer and reverse-phase purified; purity was assessed
using PAGE analysis. Complexes were prepared as described previously
(Hare et al., 2010).
Prior to biophysical analyses, including small-angle scattering, protein alone
or intasome complexes were purified on a Superdex 200 column (GE Health-
care, Waukesha, WI, USA), concentrated with a 10 kD Amicon Ultra concen-
trator (Millipore, Billerica, MA, USA), and dialyzed using a 6–8 kD cutoff
D-tube dialyzer (Novagen, Madison, WI, USA). All measurements in this study
were performed in 20 mM HEPES (pH 7.4), 320 mM NaCl, 10 mMZnOAc2, and
1–10 mM dithiothreitol (DTT).
Size-Exclusion Chromatography and Multiangle Light Scattering
Absolute molecular weights of PFV IN were determined using MALS (Wyatt
Technology Corporation, Santa Barbara, CA, USA), coupled with a Superdex
200 10/300 GL column (GE Healthcare). This analysis and Stokes radius (Rs)
determination were performed as previously described (Gupta et al., 2010).
For determination of absolutemolecular weight of PFV intasome, amass-aver-
aged dn/dc of 0.182 ml/g was used to account for the DNA component.
Analytical Ultracentrifugation
Sedimentation equilibrium (SE) and sedimentation velocity (SV) experiments
were performed at 4C and 25C, respectively, with an XL-A analytical ultra-
centrifuge (Beckman Coulter, Fullerton, CA, USA) and a TiAn60 rotor with
charcoal-filled epon centerpieces and quartz windows. For SE analysis, radial
absorption scan data at 295 nm for three protein concentrations were mea-
sured at 16 and 18 hr for each of the three different rotor speeds (28,000,
30,000, and 32,000 rpm). Data were analyzed using the programs SEDFIT
(Schuck, 2000) and SEDPHAT (Vistica et al., 2004). An estimated error for
the determined mass was determined from a 1,000-iteration Monte Carlo
simulation, as implemented in SEDPHAT. For SV analysis, complete absor-1926 Structure 20, 1918–1928, November 7, 2012 ª2012 Elsevier Ltdbance profiles at 280 nm were collected every 30 s at 45,000 rpm, followed
by data analysis using the program SEDFIT. For all analyses, a standard value
of 0.73 cm3/g was used for partial specific volume (vbar) of PFV IN and
0.59 cm3/g for DNA. SEDNTERP (Laue et al., 1992) was used to calculate
values for buffer viscosity (h, 0.01 poise) and the density of the buffer
(r, 1.0079 g/cm3).
Small-Angle Scattering and Molecular Modeling
X-ray scattering data were measured at three different sources: beamline G1
at Cornell University High Energy Synchrotron Source (CHESS, Ithaca, NY,
USA), beamline 18-ID at Argonne National Laboratory (APS BioCAT, Argonne,
IL, USA), and beamline 12.3.1 at the Advanced Light Source (ALS SIBYLS,
Berkeley, CA, USA). Neutron scattering data were collected on the NG3
30 m SANS instrument at the National Institute for Standards and Technology
(NIST, Gaithersburg, MD, USA.). Specific details of the experimental setup and
procedures specific to each location, and to the molecular modeling methods
employed, are provided in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.str.2012.08.023.
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